Apple bought the company Gliimpse

Apple bought Gliimpse, a company specialized in monitoring users' health and recording data on physical exercises. Gliimpse was a startup that attracted the attention of quite a large number of investors, the Apple company completing the acquisition at the beginning of this year.

Based on existing information, Gliimpse has created a technology that collects a multitude of biometric data, their software offering the option that these data can be personalized and organized in a format that allows sharing on social networks with the idea of ​​forming an image of the evolution of a user's health.

The Gliimpse company was founded in 2013 by an entrepreneur named Anil Sethi, who wanted to create a simple method to monitor the health of his cancer-stricken sister. As it generally happens in cases of this kind, something useful for many people is born from a desire to help someone, and Gliimpse technology will end up in Apple products.

Through Gliimpse technology, users of Apple products will be able to manage their health information and share it securely with anyone they want. The company had a special platform for this and could be integrated with certain applications, which could be extremely useful in the case of large hospitals in the US.

Gliimpse™ began with a simple idea – everyone should be able to manage their health records, and share them securely with those they trust. Currently in stealth, Gliimpse is healthcare's platform for building patient-centric apps. By unlocking hospital silos, we aggregate fragmented data into Medicare mandated patient summaries. Gliimpse is your personal health history, in the palm of your hands.

With Gliimpse, users can create a virtual diary regarding their physical or mental health, enter details regarding the results of the tests performed, enter information regarding the level of pain felt at certain times of the day and share this data securely with the doctor who take care

The purchase of Gliimpse is a new proof that Apple is extremely interested in developing new products for health monitoring and it remains to be seen how everything will be integrated in the future products of the Americans.

impse him